NewGenIvf (NASDAQ: NIVF) to cut share count with 1-for-3 split
Rhea-AI Filing Summary
NewGenIvf Group Limited (NIVF) reports that its board approved a reverse stock split of all issued and unissued shares, including Class A and Class B ordinary shares and preferred shares, at a ratio of one share for every three shares. Under the BVI Business Companies Act and the company’s M&A, the board can implement this action without a shareholder vote, and no shareholder approval will be sought.
The reverse stock split will be effective at 12:01 a.m. (ET) on September 1, 2026, and Class A ordinary shares will begin trading on Nasdaq on a split-adjusted basis that day, continuing under the symbol “NIVF” with a new CUSIP. The number of outstanding Class A ordinary shares will be reduced from 6,307,870 to approximately 2,102,623, with every three existing shares automatically combined into one. No fractional shares will be issued; holders otherwise entitled to a fraction will receive one whole post-split share. Outstanding options, warrants and other convertible securities will be proportionally adjusted by dividing the underlying share amounts by three, subject to rounding, while par value remains nil and the company’s unlimited authorized share capital is unchanged.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
reverse stock split financial
BVI Business Companies Act regulatory
par value financial
Nasdaq Capital Market market
FAQ
What reverse stock split did NewGenIvf Group Limited (NIVF) approve?
When does the NIVF reverse stock split become effective and when does split-adjusted trading start?
How will the NIVF reverse stock split affect options, warrants and other convertible securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.